Valeant Pharmaceuticals International Inc said it increased its offer for Salix Pharmaceuticals Inc to $173 per share, hoping to end a bidding war with Endo International Plc for the bowel drug maker. Valeant agreed to purchase Salix last month for $158 per share in cash. Endo then offered about $175 per share in cash and stock for Salix last week.
Shares of ENDP fell by 3.5% or $-3.17/share to $87.33. In the past year, the shares have traded as low as $53.62 and as high as $92.80. On average, 3025840 shares of ENDP exchange hands on a given day and today's volume is recorded at 4632802.
Shares of ENL fell by 2.66% or $-3.08/share to $112.92. In the past year, the shares have traded as low as $59.50 and as high as $116.00. On average, 903 shares of ENL.TO exchange hands on a given day and today's volume is recorded at 336.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 2.5% or $4.81/share to $197.43. In the past year, the shares have traded as low as $106.00 and as high as $206.84. On average, 3111320 shares of VRX exchange hands on a given day and today's volume is recorded at 4796781.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 3.25% or $7.95/share to $252.29. In the past year, the shares have traded as low as $116.01 and as high as $263.91. On average, 417685 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 408224.
Source
